Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00499
|
|||||
| Drug Name |
Corticosterone
|
|||||
| Synonyms |
(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE; (11beta)-11,21-Dihydroxypregn-4-ene-3,20-dione; 11,12-Dihydroxyprogesterone; 11,21-Dihydroxyprogesterone; 11-Hydroxycorticoaldosterone; 11-beta,21-Dihydroxypregn-3,20-dione; 11Beta,21-dihydroxypregn-4-ene-3,20-dione; 11beta,21-Dihydroxy-4-pregnene-3,20-dione; 11beta,21-Dihydroxyprogesterone; 17-Deoxycortisol; 4-Pregnene-11beta,21-diol-3,20-dione; 50-22-6; CCRIS 6753; CHEBI:16827; Compound B; Corticosteron; Corticosterone; Kendall's compound B; NSC9705; Reichstein's B; Reichstein's substance H; UNII-W980KJ009P
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Coxarthrosis [ICD11: FA00] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H30O4
|
|||||
| Canonical SMILES |
CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
|
|||||
| InChI |
InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1
|
|||||
| InChIKey |
OMFXVFTZEKFJBZ-HJTSIMOOSA-N
|
|||||
| CAS Number |
CAS 50-22-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 346.5 | Topological Polar Surface Area | 74.6 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321632
, 11466460
, 11467580
, 11486119
, 17389502
, 17404783
, 24278302
, 24856812
, 24869860
, 25630774
, 26751495
, 26758495
, 29224789
, 46386953
, 46504547
, 47275526
, 47646532
, 48018879
, 48243330
, 48318377
, 48393901
, 48393902
, 48421980
, 48424986
, 49698488
, 49956045
, 50104040
, 5219
, 53777326
, 53788667
, 53834312
, 56311825
, 56312404
, 56312772
, 56313244
, 56423132
, 57322931
, 57390013
, 57648276
, 57650717
, 58685480
, 6435953
, 75084
, 7886418
, 7978988
, 804393
, 8143631
, 8153530
, 841767
, 855741
|
|||||
| ChEBI ID |
CHEBI:16827
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01079455) Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip | |||||
| 2 | Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.